Home » Lysophosphatidylethanolamine 18:1 drives clear cell renal cell carcinoma by stabilizing SIRT6 to reprogram lipid metabolism – Signal Transduction and Targeted Therapy
Lysophosphatidylethanolamine 18:1 drives clear cell renal cell carcinoma by stabilizing SIRT6 to reprogram lipid metabolism – Signal Transduction and Targeted Therapy
by Yue, Nanxi, Zhao, Hongye, Zhang, Yong, Gu, Junfei, Qi, Jinchun, Wen, Jinkun, Wang, Wei, Lv, Mingming, Sun, Hao, Chen, Jinsuo, Yang, Chenxiao, Qu, Changbao, Chen, Xiaonan & Yang, Zhan | Dec 8, 2025 | Articles |
